HLLFH - Overview: Hematologic Disorders, Leukemia/Lymphoma; Flow Hold, Varies
Evaluating lymphocytoses of undetermined etiology Identifying B- and T-cell lymphoproliferative disorders involving blood and bone marrow Distinguishing acute lymphoblastic leukemia (ALL) from acute myeloid leukemia (AML) Immunologic...
TTFB - Overview: Testosterone, Total, Bioavailable, and Free, Serum
Second- or third-order test for evaluating testosterone status (eg, when abnormalities of sex hormone-binding globulin are present)
TGRP - Overview: Testosterone, Total and Free, Serum
Alternative, second-level test for suspected increases or decreases in physiologically active testosterone: -Assessment of androgen status in cases with suspected or known sex hormone-binding globulin-binding abnormalities -Assessment of...
HL57R - Overview: HLA-B*57:01 Genotype, Pharmacogenomics, Varies
Identifying individuals with an increased risk of hypersensitivity reactions to abacavir, based on the presence of the human leukocyte antigen HLA-B*57:01 allele Identifying individuals taking pazopanib who have an increased risk of...
NGHIS - Overview: MayoComplete Histiocytic Neoplasms, Next-Generation Sequencing, Varies
Aiding in establishing diagnosis, refining prognosis, and potentially identifying targeted therapies for the optimal management of patients with histiocytic neoplasms
NGTCL - Overview: MayoComplete T-Cell Lymphoma, Next-Generation Sequencing, Varies
Aiding in establishing diagnosis, refining prognosis, and potentially identifying targeted therapies for the optimal management of patients with T-cell lymphomas
Evaluation of acute myeloid leukemia using a focused 4-gene panel at the time of diagnosis, or possibly relapsed or refractory disease, to help guide possible therapeutic approaches
Simultaneous detection and differentiation of SARS-CoV-2 (cause of COVID-19), influenza A virus, and influenza B virus in upper or lower respiratory tract specimens from individuals with flu-like illnesses
PSAFT - Overview: Prostate-Specific Antigen (PSA), Total and Free, Serum
As an aid in distinguishing prostate cancer from benign prostatic conditions in men aged 50 years and older with total PSA between 4.0 and 10.0 ng/mL with digital rectal examination findings that are not suspicious for cancer
Aiding in the diagnosis of Helicobacter pylori infection and prediction of clarithromycin resistance or susceptibility directly from gastric biopsies
MCL TCR V Beta Spectratyping Assay Patient Information MC1235204
MCL TCR Beta Spectratyping Assay Patient Information Complete print TCR beta Spectratyping Assay Patient Information Reset Form Instructions Provide requested clinical information
Prostate Health Index (phi) [A Test in Focus] (Spanish) - Insights
https://www.youtube.com/watch?v=D5Q12Fk-J2Q
Week in Review: May 6 - Insights
watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision...
Patient Information and Signature Forms - Mayo Clinic Laboratories
Patient Information and Signature Forms A B C D E F G H I J K...
MCL Coagulation Test Request Form T753 MC076704A
MCL Coagulation Test Request Form T753 Complete print Reset Form Coagulation Test Request Client Information required Client Patient Information required Patient ID Medical Record